CEACAM5 and malignant colon neoplasm: In conclusion, we discovered for the first time that the combination of serum TC, HDL, CEA and CA19–9 can serve as an effective marker for colon cancer, and offer a novel strategy for clinical diagnosis and monitoring the disease.